Cite

    Dagnew, A. et al. (2021). Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials. Rheumatology. pp. 1226-1233. [Online].